| Name | Title | Contact Details |
|---|
Boston Brace International is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Boston Brace International is based in Avon, MA. You can find more information on Boston Brace International at www.bostonbrace.com
Since its inception more than 55 years ago, Memorial Healthcare System has been a leader in providing high-quality healthcare services to South Florida residents. Today, it is the fifth-largest public healthcare system in the nation and highly regarded for its exceptional patient- and family-centered care. Memorial`s patient, physician and employee satisfaction rates are some of the most admired in the country, and the system is recognized as a national leader in quality care. To be a premier clinically integrated delivery system providing access to exceptional patient-and family-centered care, medical education, research and innovation for the benefit of the community we serve.
MedeAnalytics provides evidence-based insights to solve a real problem that plagues health care – how to use the immense amount of patient data collected along the care continuum to deliver cost – effective care and promote a healthier population. The platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics` cloud-based tools have been used to analyze more than 21 billion patient encounters in the United States and United Kingdom, providing better care to more than 30 million patients and better business for 900 healthcare organizations.
Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF`s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.
Pioneering skin cancer tools for you and your family. DermaSensor is designing an affordable handheld sensor device that will let you scan your skin for irregular lesions in seconds.